XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues $ 11,600,904 $ 10,479,899
Direct product costs (4,835,632) (4,340,292)
Gross Profit 6,765,272 6,139,607
Operating Expenses:    
Research and development 8,114,377 4,592,879
Sales and marketing 4,634,012 2,752,153
General and administrative 5,138,410 2,464,295
Total Operating Expenses 17,886,799 9,809,327
Operating Loss (11,121,527) (3,669,720)
Interest expense (874,713) (551,495)
Other income (expenses) (30,526) 1,384,060
Total Other Income (Expenses), net (905,239) 832,565
Net Loss $ (12,026,766) $ (2,837,155)
Net loss per share - basic and diluted (in dollars per share) $ (0.36) $ (0.24)
Weighted average common shares outstanding - basic and diluted (in shares) 33,302,237 11,704,201
Product [Member]    
Revenues $ 10,558,570 $ 9,827,817
Royalty and Non-recurring Engineering [Member]    
Revenues $ 1,042,334 $ 652,082